- Home
- Labeler Index
- Seqirus Inc.
- 70461-654
- NDC Crossover: 70461-654 Flucelvax
NDC Crossover 70461-654 Flucelvax
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 70461-654 – Flucelvax, . This list includes other cross-matching products that share:
- The same product name: Flucelvax
- OR Generic name:
- AND the same Administration Route:
- OR Dosage Form:
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 70461-555 | Flucelvax | Influenza A Virus A/georgia/12/2022 Cvr-167 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza A Virus A/victoria/800/2024 Cvr-289 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated),influenza B Virus B/singapore/wuh4618/2021 Antigen (mdck Cell Derived, Propiolactone Inactivated) | Injection, Suspension | Intramuscular | Seqirus Inc. | Vaccine |
| 70461-655 | Flucelvax | Influenza A Virus A/georgia/12/2022 Cvr-167 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza A Virus A/victoria/800/2024 Cvr-289 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/singapore/wuh4618/2021 Antigen (mdck Cell Derived, Propiolactone Inactivated) | Injection, Suspension | Intramuscular | Seqirus Inc. | Vaccine |
